The Latest SPAC News and Rumors: October 27, 2021
by Marlena Haddad on 2021-10-27 at 11:55am

Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News: Tim Hortons China hits 300 stores, Science 37 collaborates with 3H Medi Solution to enable decentralized clinical trials in Japan, and DocGo triples third quarter revenues


Tim Hortons China Hits 300 Stores Undeterred by Listing Delay

TH International Ltd., also known as Tims China, a joint venture of Restaurant Brands International Inc. and the private equity firm Cartesian Capital Group, said it has opened its 300th store in the world’s most populous country. The more than two-fold jump — it had 137 outlets at the beginning of 2021 — underscores the coffee chain’s big bet on China despite recurring flare-ups of Covid-19 that has curtailed consumer demand and triggered curbs on movement.

READ

Science 37 and 3H Medi Solution Collaborate to Enable Decentralized Clinical Trials in Japan and Accelerate Patient Enrollment

Science 37, the Operating System for today’s more agile clinical trials and 3H Medi Solution Inc., a clinical trials solution leader in Japan today announced a collaboration to further decentralized clinical trials and accelerate the development of therapies. In this partnership, 3H Medi Solution will use Science 37’s clinical trial Operating System with its end-to-end technology platform for eConsent, electronic data capture, patient management, telemedicine and mobile nurse operations.

On October 7, Science 37, Inc. (NASDAQ:SNCE) completed its business combination with LifeSci Acquisition II Corp.

READ

DocGo Continues on Exponential Growth Track; Triples Third Quarter Revenues, Enters New Markets and Secures Major Partnerships

DocGo, a leading provider of last-mile mobile health services and integrated medical mobility solutions that has entered into an agreement to merge with Motion Acquisition Corp. (NASDAQ:MOTN), continues on its exponential growth trajectory, reporting Q3 revenues of $81 million, a 200% increase over the previous year, and rolling out a series of major initiatives and joint partnerships.

With continued growth on the horizon, the mobile health services company is poised to disrupt the healthcare industry with its combined Mobile Health and medical transportation offering.  DocGo is the current operating trade name for Ambulnz, Inc. Upon consummation of the merger, the combined company will be renamed DocGo, Inc.

READ

 

The Latest SPAC News and Rumors: October 27, 2021
Recent Posts
by Nicholas Alan Clayton on 2025-07-01 at 7:51pm

Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....

by Nicholas Alan Clayton on 2025-07-01 at 7:47pm

Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....

by Nicholas Alan Clayton on 2025-07-01 at 7:19pm

1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...

by Nicholas Alan Clayton on 2025-07-01 at 3:49pm

D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...

by Nicholas Alan Clayton on 2025-07-01 at 11:33am

Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved